Bovine Respiratory Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Bovine Respiratory Disease (BRD) Treatment System Market Share and is segmented by Treatment Type (Vaccines, Antibiotics, NSAIDs, Immunomodulators, and Other Treatment Types), Disease Type (Lower Respiratory Tract Infections, Upper Respiratory Tract Infections, Diphtheria), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The report offers the value (in USD million) for the above segments.

Bovine Respiratory Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Bovine Respiratory Disease Treatment Market Size

Bovine Respiratory Disease Treatment Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 11.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Bovine Respiratory Disease Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Bovine Respiratory Disease Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Bovine Respiratory Disease Treatment Market Analysis

The Bovine Respiratory Disease Treatment Market is expected to register a CAGR of 11.5% during the forecast period.

The COVID-19 pandemic disrupted animal health care during the initial stages of the pandemic. The strict lockdown imposition of lockdown affected the accessibility to veterinary clinics, thus impacting the market's growth over the pandemic phase. According to the study published in the Indian Journal of Animal Science in June 2022, there was a significant difference in the number of cases attended across different lockdown periods and among veterinarians, with a decline in the number of cases attended across pet species (54.9%), followed by goats (35.3%), sheep (29.1%), cattle (25.5%), and buffalo (21.6%). During the lockdown, veterinarian visits fell by 27.3%, while farmer visits to veterinary clinics fell by 61.9%, thus impacting the market growth adversely in the initial pandemic phase. However, with the resumption of veterinary services worldwide, the market is likely to gain traction over the forecast period.

The increasing consumption of beef and the rising population are the major factors driving the market studied. According to the article published in TWC in 2022, the global beef consumption stood at 350 million tons a year, and by 2050 the global meat consumption is projected to reach between 460 million. As a result, global beef consumption is increasing, which necessitates greater attention to livestock diseases such as bovine respiratory diseases, thereby contributing to the market's growth over the forecast period.

In addition, Bovine Respiratory Disease (BRD) adversely affects the reproductive performance, growth, and lifespan of cattle. Hence, this necessitates the need for BRD treatment globally. According to the Elsevier article published in 2021, the average cumulative incidence of bovine respiratory disease in high-performing livestock was 12.8% and among the high-risk group of livestock was 15.1%. Thus, the growing prevalence of bovine respiratory diseases among livestock is expected to contribute to the market's growth over the forecast period.

Also, various market players are taking strategic initiatives for the development of new products and strengthening their position in the market. For instance, in August 2021, Zoetis launched a new combination product to treat Bovine Respiratory Disease (BRD) and control related fever (pyrexia): Draxxin KP (tulathromycin and ketoprofen injection) Injectable Solution.

Thus, all the aforementioned factors, such as rising meat consumption, increasing bovine respiratory diseases, and rising product launches, are expected to boost the market's growth. However, the shortage of skilled veterinarians may restrain the market's growth.

Bovine Respiratory Disease Treatment Industry Overview

The Market for Bovine Respiratory Disease Treatment is moderately competitive. There are a few global players that hold most of the market share. Hence, it is expected that these companies will have a substantial market share in the coming future. Some of the players are Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, and others.

Bovine Respiratory Disease Treatment Market Leaders

  1. Boehringer Ingelheim GmbH

  2. Virbac

  3. Zoetis

  4. Ceva Sante Animale

  5. Elanco Animal Health

  6. *Disclaimer: Major Players sorted in no particular order
Bovine Respiratory Disease Treatment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Bovine Respiratory Disease Treatment Market News

  • August 2022: researchers in the University of Lethbridge's Southern Alberta Genome Science Centre (SAGSC) and its bioinformatics core collaborated with scientists at Agriculture and Agri-Food Canada to find viable solutions to mitigate bovine respiratory disease.
  • March 2022: Merck Animal Health received United States FDA approval for AROVYN (tulathromycin injection) - a broad-spectrum, prescription antibiotic that treats the major organisms associated with bovine respiratory disease (BRD), foot rot, and pinkeye.

Bovine Respiratory Disease Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of BRD (Bovine Respiratory Diseases)
    • 4.2.2 Increasing Consumption of Beef
    • 4.2.3 Changing Environmental Factors
  • 4.3 Market Restraints
    • 4.3.1 Shortage of Skilled Veterinarians
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Treatment Type
    • 5.1.1 Vaccines
    • 5.1.2 Antibiotics
    • 5.1.3 NSAIDs
    • 5.1.4 Immunomodulators
    • 5.1.5 Other Treatment Tyes
  • 5.2 By Diseases Type
    • 5.2.1 Lower Respiratory Tract Infections
    • 5.2.2 Upper Respiratory Tract Infections
    • 5.2.3 Diphtheria
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bimeda
    • 6.1.2 Boehringer Ingelheim GmbH
    • 6.1.3 Ceva
    • 6.1.4 Elanco
    • 6.1.5 Merck & Co. Inc.
    • 6.1.6 Vetoquinol
    • 6.1.7 Virbac
    • 6.1.8 Zoetis Inc.
    • 6.1.9 Bayer AG
    • 6.1.10 Idexx laboratories
    • 6.1.11 Indian Immunologicals Ltd
    • 6.1.12 Ourofino Saude Animal
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Bovine Respiratory Disease Treatment Industry Segmentation

As per the scope of the report, Bovine Respiratory Disease (BRD) is the general term used for respiratory diseases in cattle or bovines. BRD is usually caused by both viral and bacterial pathogens and can affect the lower respiratory tract and upper respiratory tract. 

The Bovine Respiratory Disease Treatment market is segmented by Treatment Type (Vaccines, Antibiotics, NSAIDs, Immunomodulators, and Other Treatment Types), Disease Type (Lower Respiratory Tract Infections, Upper Respiratory Tract Infections, Diphtheria), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Treatment Type Vaccines
Antibiotics
NSAIDs
Immunomodulators
Other Treatment Tyes
By Diseases Type Lower Respiratory Tract Infections
Upper Respiratory Tract Infections
Diphtheria
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Bovine Respiratory Disease Treatment Market Research FAQs

What is the current Bovine Respiratory Disease Treatment Market size?

The Bovine Respiratory Disease Treatment Market is projected to register a CAGR of 11.5% during the forecast period (2025-2030)

Who are the key players in Bovine Respiratory Disease Treatment Market?

Boehringer Ingelheim GmbH, Virbac, Zoetis, Ceva Sante Animale and Elanco Animal Health are the major companies operating in the Bovine Respiratory Disease Treatment Market.

Which is the fastest growing region in Bovine Respiratory Disease Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Bovine Respiratory Disease Treatment Market?

In 2025, the North America accounts for the largest market share in Bovine Respiratory Disease Treatment Market.

What years does this Bovine Respiratory Disease Treatment Market cover?

The report covers the Bovine Respiratory Disease Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Bovine Respiratory Disease Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Bovine Respiratory Disease Treatment Industry Report

Statistics for the 2025 Bovine Respiratory Disease Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bovine Respiratory Disease Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Bovine Respiratory Disease Treatment Market Report Snapshots